福建海西新药创制股份有限公司（简称“海西新药”，股票代码：02637）于2026年10月6日发布截至2026年9月30日的证券变动月报表。报告显示，9月期间公司股本保持稳定，未发生新增发行、购回、注销或库藏股变动。
公司本月法定（注册）股本为人民币78,707,270元，面值为每股人民币1元，于报告期内未发生增减变动；已发行股份总数（不含库存股）亦维持78,707,270股，无库 存股。公司确认符合香港联合交易所有限公司的最低公众持股量要求。
同时，公司9月期间无涉及股份期权、权证或可转债相关的发行或变动，也未订立任何其他有待发行股份的协议或安排。公司股份期权及激励计划均无更新。
本次月报表由联席公司秘书张俊环签署。公司表示，已持续遵守香港联交所《上市规则》及相关法律法规的规定，整体股本状况保持不变。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.